61 results
Page 2 of 4
6-K
EX-1.1
q9p sfhvwevv17rju5
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
23ld hmp5k5e
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
04riade6
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
ivmxcd1p2
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
EX-12.1
rb7ehd5r
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
7jy3x
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
jmsze
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
qhq9da40se zz
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
gbxob1c sxfaf7xs
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
nemiwdc 0ozaxh918ks
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
571g0rrbaeof8s47hf
10 Jul 19
Prospectus supplement
8:18am
F-3
afep 0c4bma3s1ykf
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
mzu hs13k6yex
7 Jun 19
Shelf registration (foreign)
3:31pm